Literature DB >> 15081850

Dose reduction to radiosensitive tissues in CT. Do commercially available shields meet the users' needs?

D J McLaughlin1, R B Mooney.   

Abstract

AIM: To assess the effectiveness and economy of routinely using commercially available in-plane bismuth shielding during CT scanning of the chest and brain. METHODS AND MATERIALS: Forty patients were scanned with thermoluminescent dosemeters (TLDs) in situ to measure the radiation dose to the thyroid and eye during CT scanning of the brain and chest. Half of the patients had the "AttenuRad" shield in place during scanning.
RESULTS: Use of the shielding reduced the mean dose to the eye from 6.0 +/- 0.3 mGy to 4.9 mGy +/- 0.2 mGy and the thyroid dose from 16.4 mGy +/- 1.2 mGy to 7.1 mGy +/- 0.5 mGy.
CONCLUSION: Use of the thyroid shield is recommended for all CT scanning of the chest. The eye shield does not produce as marked a reduction in radiation dose to the lens of the eye, when an angled gantry is used, since the eyes are not in the primary beam. Use of the eyeshield is justifiable where irradiation of the orbit is unavoidable, although whether artifacts would be a problem if the shield was used in this way was not assessed.

Entities:  

Mesh:

Year:  2004        PMID: 15081850     DOI: 10.1016/j.crad.2003.10.016

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  17 in total

1.  Bismuth shielding in CT: support for use in children.

Authors:  Sangroh Kim; Donald P Frush; Terry T Yoshizumi
Journal:  Pediatr Radiol       Date:  2010-08-24

2.  Organ-based tube current modulation in a clinical context: Dose reduction may be largely overestimated in breast tissue.

Authors:  André Euler; Zsolt Szucs-Farkas; Anna L Falkowski; Nadine Kawel-Böhm; Luigia D'Errico; Sebastién Kopp; Jens Bremerich; Tilo Niemann
Journal:  Eur Radiol       Date:  2015-11-12       Impact factor: 5.315

3.  Quantitative assessment of selective in-plane shielding of tissues in computed tomography through evaluation of absorbed dose and image quality.

Authors:  J Geleijns; M Salvadó Artells; W J H Veldkamp; M López Tortosa; A Calzado Cantera
Journal:  Eur Radiol       Date:  2006-04-08       Impact factor: 5.315

4.  CT dose and image quality in the last three scanner generations.

Authors:  Andreas Christe; Johannes Heverhagen; Christoph Ozdoba; Christian Weisstanner; Stefan Ulzheimer; Lukas Ebner
Journal:  World J Radiol       Date:  2013-11-28

5.  Breast dose reduction with organ-based, wide-angle tube current modulated CT.

Authors:  Wanyi Fu; Gregory M Sturgeon; Greeshma Agasthya; William Paul Segars; Anuj J Kapadia; Ehsan Samei
Journal:  J Med Imaging (Bellingham)       Date:  2017-08-04

6.  Effect of leaded glasses and thyroid shielding on cone beam CT radiation dose in an adult female phantom.

Authors:  A D Goren; R D Prins; L T Dauer; B Quinn; A Al-Najjar; R D Faber; G Patchell; I Branets; D C Colosi
Journal:  Dentomaxillofac Radiol       Date:  2013-02-14       Impact factor: 2.419

7.  Decreasing the effective radiation dose in pediatric craniofacial CT by changing head position.

Authors:  Ryne A Didier; Anna A Kuang; Daniel L Schwartz; Nathan R Selden; Donna M Stevens; Dianna M E Bardo
Journal:  Pediatr Radiol       Date:  2010-08-05

8.  Dose reduction in multislice CT by means of bismuth shields: results of in vivo measurements and computed evaluation.

Authors:  P Catuzzo; S Aimonetto; G Fanelli; P Marchisio; T Meloni; L Mistretta; M Pasquino; E Richetta; S Tofani
Journal:  Radiol Med       Date:  2009-12-14       Impact factor: 3.469

9.  Dose reduction in CT using bismuth shielding: measurements and Monte Carlo simulations.

Authors:  Kyung-Hwan Chang; Wonho Lee; Dong-Myung Choo; Choon-Sik Lee; Youhyun Kim
Journal:  Radiat Prot Dosimetry       Date:  2009-12-03       Impact factor: 0.972

10.  In-plane shielding for CT: effect of off-centering, automatic exposure control and shield-to-surface distance.

Authors:  Mannudeep K Kalra; Pragya Dang; Sarabjeet Singh; Sanjay Saini; Jo-Anne O Shepard
Journal:  Korean J Radiol       Date:  2009-03-03       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.